A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVIDStefanie M. Bader, David Komander, Merle Dayton et al.|Nature Communications|2025Cited by 35
SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlatesStefanie M. Bader, Marc Pellegrini, James P. Cooney et al.|Proceedings of the National Academy of Sciences|2023Cited by 29
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivoStefanie M. Bader, Marcel Doerflinger, James P. Cooney et al.|Cell Death and Disease|2024Cited by 14
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signallingStefanie M. Bader, Marcel Doerflinger, L.R. Scherer et al.|Cell Death and Differentiation|2025Cited by 8
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infectionStefanie M. Bader, Marcel Doerflinger, L.R. Scherer et al.|Nature Communications|2025Cited by 4